Yaqubi H, May T, Burton A
Drug Alcohol Rev. 2025; 44(3):858-870.
PMID: 39935079
PMC: 11886483.
DOI: 10.1111/dar.14013.
Schutz C, Nicholls T, Schmid L, Penner S, Massey M, Thiessen K
Can J Psychiatry. 2025; :7067437251315516.
PMID: 39901488
PMC: 11795578.
DOI: 10.1177/07067437251315516.
Marshall T, Reeson M, Loverock A, Lewis A, King I, Ilyas R
Can J Psychiatry. 2025; 7067437241300957.
PMID: 39763221
PMC: 11705303.
DOI: 10.1177/07067437241300957.
Wani K, Rather Y, Kousar M, Bhat F, Rasool U
Indian J Psychol Med. 2024; :02537176241257673.
PMID: 39564241
PMC: 11572310.
DOI: 10.1177/02537176241257673.
Szerman N, Parro C, Vega P, Basurte-Villamor I, Ruiz-Veguilla M
Front Psychiatry. 2024; 15:1427561.
PMID: 39465048
PMC: 11502350.
DOI: 10.3389/fpsyt.2024.1427561.
Definition, assessment and treatment of cognitive impairment associated with schizophrenia: expert opinion and practical recommendations.
Vita A, Barlati S, Cavallaro R, Mucci A, Riva M, Rocca P
Front Psychiatry. 2024; 15:1451832.
PMID: 39371908
PMC: 11450451.
DOI: 10.3389/fpsyt.2024.1451832.
Dual diagnosis and their care pathways for help-seeking: A multicenter study from India.
Ghosh A, Mukherjee D, Khanra S, Prasad S, Mahintamani T, Basu A
Indian J Psychiatry. 2024; 66(7):630-640.
PMID: 39257507
PMC: 11382752.
DOI: 10.4103/indianjpsychiatry.indianjpsychiatry_79_24.
Key conditions for the successful implementation of evidence-based practice in concurrent disorder nursing care with the ECHO® model: Insights from a mixed-methods study.
Chicoine G, Cote J, Pepin J, Pluye P, Jutras-Aswad D
Int J Nurs Stud Adv. 2024; 5:100153.
PMID: 38746592
PMC: 11080413.
DOI: 10.1016/j.ijnsa.2023.100153.
Training in Substance use Disorders, Part 1: Overview of Clinical Practice Recommendations.
Bahji A, Crockford D, Brasch J, Schutz C, Buckley L, Danilewitz M
Can J Psychiatry. 2024; 69(6):428-456.
PMID: 38613369
PMC: 11107443.
DOI: 10.1177/07067437241231128.
Navigating the Complex Intersection of Substance Use and Psychiatric Disorders: A Comprehensive Review.
Bahji A
J Clin Med. 2024; 13(4).
PMID: 38398311
PMC: 10889170.
DOI: 10.3390/jcm13040999.
Third-Generation Antipsychotics and Lurasidone in the Treatment of Substance-Induced Psychoses: A Narrative Review.
Ricci V, de Berardis D, Maina G
Healthcare (Basel). 2024; 12(3).
PMID: 38338224
PMC: 10855531.
DOI: 10.3390/healthcare12030339.
Components of Outpatient Child and Youth Concurrent Disorders Programs: A Critical Interpretive Synthesis: Composantes des programmes de troubles concomitants des enfants et des jeunes ambulatoires : une synthèse interprétative critique.
Rosic T, Lovell E, MacMillan H, Samaan Z, Morgan R
Can J Psychiatry. 2023; 69(6):381-394.
PMID: 37941334
PMC: 11107442.
DOI: 10.1177/07067437231212037.
Utilising the Implementation of Integrated Care to Develop a Pragmatic Framework for the Sustained Uptake of Service Innovations (SUSI).
Foley C, Allan J, Lappin J, Courtney R, Farnbach S, Henderson A
Healthcare (Basel). 2023; 11(12).
PMID: 37372904
PMC: 10298662.
DOI: 10.3390/healthcare11121786.
'The Addiction Was Making Things Harder for My Mental Health': A Qualitative Exploration of the Views of Adults and Adolescents Accessing a Substance Misuse Treatment Service.
Spencer L, Alderson H, Scott S, Kaner E, Ling J
Int J Environ Res Public Health. 2023; 20(11).
PMID: 37297571
PMC: 10253073.
DOI: 10.3390/ijerph20115967.
A scoping review of psychiatric conditions associated with chronic pain in the homeless and marginally housed population.
Rintoul K, Song E, McLellan-Carich R, Schjelderup E, Barr A
Front Pain Res (Lausanne). 2023; 4:1020038.
PMID: 37187857
PMC: 10175796.
DOI: 10.3389/fpain.2023.1020038.
Health outcomes and service use patterns associated with co-located outpatient mental health care and alcohol and other drug specialist treatment: A systematic review.
Glover-Wright C, Coupe K, Campbell A, Keen C, Lawrence P, Kinner S
Drug Alcohol Rev. 2023; 42(5):1195-1219.
PMID: 37015828
PMC: 10946517.
DOI: 10.1111/dar.13651.
Establishing a System of Care for Severe and Refractory Dual Disorder in the State of Hawai'i.
Busch G, Seo J
Hawaii J Health Soc Welf. 2023; 81(12 Suppl 3):19-26.
PMID: 36660278
PMC: 9783815.
Enhancing nurses' capacity to provide concurrent mental health and substance use disorder care: A quasi-experimental intervention study.
Jenkins E, Currie L, Hirani S, Garrod E, Goodyear T, McGuinness L
Nurse Educ Today. 2022; 117:105483.
PMID: 35908405
PMC: 9970037.
DOI: 10.1016/j.nedt.2022.105483.
Experiences and perceptions of nurses participating in an interprofessional, videoconference-based educational programme on concurrent mental health and substance use disorders: a qualitative study.
Chicoine G, Cote J, Pepin J, Boyer L, Rouleau G, Jutras-Aswad D
BMC Nurs. 2022; 21(1):177.
PMID: 35787275
PMC: 9251915.
DOI: 10.1186/s12912-022-00943-w.
TOBACCO USE DISORDER AND DUAL DISORDERS Joint statement by the Spanish Psychiatry Society and the Spanish Dual Disorders Society.
Nestor S, Carlos P, Cristina P, Jose M, Ignacio B, Pilar S
Actas Esp Psiquiatr. 2022; 50(Supplement):77-138.
PMID: 35731182
PMC: 11095114.